# FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Chemoradiotherapy in Patients With Esophageal Adenocarcinoma

> **NCT02037048** · PHASE2 · UNKNOWN · sponsor: **Case Comprehensive Cancer Center** · enrollment: 63 (actual)

## Conditions studied

- Adenocarcinoma of the Esophagus
- Adenocarcinoma of the Gastroesophageal Junction
- Adenocarcinoma of the Gastric Cardia
- Stage IIIA Esophageal Cancer
- Stage IIIB Esophageal Cancer
- Stage IIIC Esophageal Cancer

## Interventions

- **DRUG:** oxaliplatin
- **DRUG:** leucovorin calcium
- **DRUG:** fluorouracil
- **PROCEDURE:** therapeutic conventional surgery
- **RADIATION:** radiation therapy
- **DRUG:** carboplatin
- **DRUG:** paclitaxel

## Key facts

- **NCT ID:** NCT02037048
- **Lead sponsor:** Case Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-02-10
- **Primary completion:** 2022-03-18
- **Final completion:** 2025-10-01
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2024-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02037048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02037048, "FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Chemoradiotherapy in Patients With Esophageal Adenocarcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02037048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*